Get the Stockscreener App
3.6203
3.21%
-0.1197
Nuvation Bio Inc stock is traded at $3.6203, with a volume of 2.83M.
It is down -3.21% in the last 24 hours and up +15.29% over the past month.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$3.74
Open:
$3.82
24h Volume:
2.83M
Relative Volume:
0.50
Market Cap:
$1.24B
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-10.34
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
-3.98%
1M Performance:
+15.29%
6M Performance:
+81.91%
1Y Performance:
+59.47%
1-Day Range:
$3.60
$3.82
1-Week Range:
$3.515
$3.82
52-Week Range:
$1.54
$4.0899
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
3.62 | 1.28B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.57 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.99 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
803.71 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.86 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Jefferies | Buy |
| Apr-23-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
Intraday pattern recognizer results for Nuvation Bio Inc.July 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Has Nuvation Bio Inc. formed a bullish divergenceWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Chart based exit strategy for Nuvation Bio Inc.Quarterly Trade Review & Reliable Entry Point Alerts - newser.com
Real time pattern detection on Nuvation Bio Inc. stockMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Applying Wyckoff theory to Nuvation Bio Inc. stock2025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Real time social sentiment graph for Nuvation Bio Inc.2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
Will Nuvation Bio Inc. stock continue dividend increasesPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Can a trend reversal in Nuvation Bio Inc. lead to recoveryWeekly Market Report & Fast Moving Stock Watchlists - newser.com
Will Nuvation Bio Inc. Class stock top growth indexesProfit Target & Safe Capital Growth Plans - newser.com
How hedge fund analytics apply to Nuvation Bio Inc. stockWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Is Nuvation Bio Inc. reversing from oversold territoryJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Is Nuvation Bio Inc. stock resilient to inflationGlobal Markets & Daily Technical Forecast Reports - newser.com
Smart tools for monitoring Nuvation Bio Inc.’s price actionWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockWeekly Market Report & Precise Entry and Exit Recommendations - newser.com
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street - Investing News Network
What market sentiment indicators show for Nuvation Bio Inc. Class stockPortfolio Gains Summary & Accurate Trade Setup Notifications - newser.com
Nuvation Bio Inc. (NUVB): A Bull Case Theory - MSN
Nuvation Bio Inc Stock Analysis and ForecastStop Loss Placement Tips & Big Gains Small Investment - earlytimes.in
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - simplywall.st
NYSE Composite Tracks Nuvation Bio’s Operational Benchmarks - Kalkine Media
How moving averages guide Nuvation Bio Inc. trading2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How Nuvation Bio Inc. Class stock moves in volatile trading sessionsMarket Growth Summary & Stepwise Trade Execution Plans - newser.com
Is Nuvation Bio Inc. Warrants stock undervalued after correctionRisk Management & Weekly High Conviction Ideas - newser.com
Will Nuvation Bio Inc. Warrants stock sustain uptrend momentum - newser.com
Can Nuvation Bio Inc. Class stock resist broad market declinesJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Is Nuvation Bio Inc. Warrants stock inflation resilientJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Nuvation Bio (NUVB) Is Up 23.3% After First Patient Enrolled in Phase 3 TRUST-IV Trial - Sahm
Custom watchlist performance reports with Nuvation Bio Inc.Earnings Growth Summary & Stepwise Swing Trade Plans - newser.com
Nuvation Bio Inc. stock retracement – recovery analysis2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
Assessing Nuvation Bio (NUVB) Valuation After Recent Share Price Momentum in the Biotech Sector - Yahoo
Nuvation Bio Hits Day High with 15.63% Surge in Strong Intraday Performance - Markets Mojo
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):